Orofacial granulomatosis associated with Crohn&#39;s disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort.

Remicade (infliximab) - J&J

Humira (adalimumab) - AbbVie

Stelara (ustekinumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Rinvoq (upadacitinib) - AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/42768927

Angelica Molinillo Marin; Cameron Herbert; Christopher A Lamb; Daniel Parkinson; Esther Hullah; Gregory Young; Jeremy Sanderson; Joel Mawdsley; Laetitia Pele; Lauren Beck; Miles Parkes; Priyanka Patel; Richard Ally Speight; Robert D Lees

Sep 23, 2026